日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

The ACE2 decoy receptor can overcome immune escape by rapid mutating SARS-CoV-2 variants and reduce cytokine induction and clot formation.

ACE2诱饵受体可以克服SARS-CoV-2快速变异株的免疫逃逸,并减少细胞因子诱导和血栓形成

Lin Ming-Shiu, Chao Tai-Ling, Chou Yu-Chi, Yi Yao, Chen Ci-Ling, Huang Kuo-Yen, Chang Sui-Yuan, Yang Pan-Chyr

Monkeypox virus H3L protein as the target antigen for developing neutralizing antibody and serological assay

以猴痘病毒H3L蛋白为靶抗原,开发中和抗体和血清学检测方法

Huang, I-Hsiang; Lai, Guan-Chun; Chao, Tai-Ling; Liu, Wang-Da; Chang, Sui-Yuan; Chang, Shih-Chung

Green Synthesis of Tetrahydropyrazino[2,1-a:5,4-a']diisoquinolines as SARS-CoV-2 Entry Inhibitors

绿色合成四氢吡嗪并[2,1-a:5,4-a']二异喹啉类化合物作为SARS-CoV-2入侵抑制剂

Palla, Sowndarya; Palla, Srinivasa Rao; Liu, Jia-Jin; Chao, Tai-Ling; Lee, Ting-Hui; Kavala, Veerababurao; Liu, I-Chen; Wang, Lily Hui-Ching; Chang, Sui-Yuan; Yao, Ching-Fa; Liang, Po-Huang

Tradeoffs between proliferation and transmission in virus evolution- insights from evolutionary and functional analyses of SARS-CoV-2

病毒进化中增殖与传播之间的权衡——来自SARS-CoV-2进化和功能分析的启示

Tai, Jui-Hung; Lee, Ding-Chin; Lin, Hsin-Fu; Chao, Tai-Ling; Ruan, Yongsen; Cheng, Ya-Wen; Chou, Yu-Chi; Lin, You-Yu; Chang, Sui-Yuan; Chen, Pei-Jer; Yeh, Shiou-Hwei; Wang, Hurng-Yi

Monkeypox virus A29L protein as the target for specific diagnosis and serological analysis

猴痘病毒A29L蛋白作为特异性诊断和血清学分析的靶标

Liang, Chia-Yu; Chao, Tai-Ling; Chao, Chong-Syun; Liu, Wang-Da; Cheng, Yu-Chen; Chang, Sui-Yuan; Chang, Shih-Chung

Correction: Lee et al. The Synergistic Inhibition of Coronavirus Replication and Induced Cytokine Production by Ciclesonide and the Tylophorine-Based Compound Dbq33b. Pharmaceutics 2022, 14, 1511

更正:Lee 等人,《环索奈德和泰洛福林类化合物 Dbq33b 对冠状病毒复制和诱导细胞因子产生的协同抑制作用》,《药物学》2022, 14, 1511

Lee, Yue-Zhi; Hsu, Hsing-Yu; Yang, Cheng-Wei; Lin, Yi-Ling; Chang, Sui-Yuan; Yang, Ruey-Bing; Liang, Jian-Jong; Chao, Tai-Ling; Liao, Chun-Che; Kao, Han-Chieh; Chang, Jang-Yang; Sytwu, Huey-Kang; Chen, Chiung-Tong; Lee, Shiow-Ju

Evolution of neutralizing antibodies and cross-activity against different variants of SARS-CoV-2 in patients recovering from COVID-19

新冠肺炎康复患者体内中和抗体的演变及其对不同SARS-CoV-2变种的交叉活性

Liu, Wang-Da; Wang, Jann-Tay; Chao, Tai-Ling; Ieong, Si-Man; Tsai, Ya-Min; Kuo, Po-Hsien; Tsai, Ming-Jui; Chen, Yi-Jie; Li, Guei-Chi; Ho, Shu-Yuan; Chen, Hui-Hou; Huang, Yu-Shan; Hung, Chien-Ching; Chen, Yee-Chun; Chang, Sui-Yuan; Chang, Shan-Chwen

Immunogenicity and safety of third-dose mRNA COVID-19 vaccines in healthy adults previously vaccinated with two doses of the ChAdOx1 vaccine.

在先前接种过两剂 ChAdOx1 疫苗的健康成年人中,第三剂 mRNA COVID-19 疫苗的免疫原性和安全性

Sheng Wang-Huei, Ieong Si-Man, Lin Pin-Hung, Hsieh Ming-Ju, Yang Hung-Chih, Pan Ching-Fu, Chao Tai-Ling, Chang Sui-Yuan, Chang Shan-Chwen

Clinical assessment of SARS-CoV-2 infectivity by rapid antigen test compared with virus isolation.

通过快速抗原检测对SARS-CoV-2传染性进行临床评估,并与病毒分离进行比较

Chao Tai-Ling, Lee Wen-Hau, Hu Hui-Chun, Lin Yi-Chun, Ho Shu-Yuan, Chen Hui-Hou, Chen Cheng-Pin, Tsai Ya-Min, Fang Jun-Tung, Leong Si-Man, Cheng Yu-Chen, Peng Mavis, Cheng Shu-Hsing, Cheng Chien-Yu, Chang Sui-Yuan

Vaccination with SARS-CoV-2 spike protein lacking glycan shields elicits enhanced protective responses in animal models

用缺乏糖基化保护层的SARS-CoV-2刺突蛋白进行疫苗接种,可在动物模型中诱导增强的保护性免疫反应。

Huang, Han-Yi; Liao, Hsin-Yu; Chen, Xiaorui; Wang, Szu-Wen; Cheng, Cheng-Wei; Shahed-Al-Mahmud, Md; Liu, Yo-Min; Mohapatra, Arpita; Chen, Ting-Hua; Lo, Jennifer M; Wu, Yi-Min; Ma, Hsiu-Hua; Chang, Yi-Hsuan; Tsai, Ho-Yang; Chou, Yu-Chi; Hsueh, Yi-Ping; Tsai, Ching-Yen; Huang, Pau-Yi; Chang, Sui-Yuan; Chao, Tai-Ling; Kao, Han-Chieh; Tsai, Ya-Min; Chen, Yen-Hui; Wu, Chung-Yi; Jan, Jia-Tsrong; Cheng, Ting-Jen Rachel; Lin, Kuo-I; Ma, Che; Wong, Chi-Huey